Dual blockade immunotherapy targeting PD-1/PD-L1 and CTLA-4 in lung cancer
Abstract Cancer immunotherapies, represented by immune checkpoint inhibitors (ICIs), have reshaped the treatment paradigm for both advanced non-small cell lung cancer and small cell lung cancer. Programmed death receptor-1/programmed death receptor ligand-1 (PD-1/PD-L1) and cytotoxic T lymphocyte-as...
Збережено в:
| Автори: | , , , |
|---|---|
| Формат: | Artigo |
| Мова: | Inglês |
| Опубліковано: |
BMC
2024-07-01
|
| Серія: | Journal of Hematology & Oncology |
| Предмети: | |
| Онлайн доступ: | https://doi.org/10.1186/s13045-024-01581-2 |
| Теги: |
Немає тегів, Будьте першим, хто поставить тег для цього запису!
|